Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Foxp3 plays a key role in CD4 + CD25 + T reg cell function in mice and represents a specific marker for these cells. Despite the strong association between FOXP3 expression and regulatory function in fresh human T cells, little is known about the dynamics of endogenous FOXP3 expression and its relation to the suppressive function in activated human T cells. Here, we addressed the dynamics of FOXP3 expression during human CD4 + T cell activation by plate‐bound anti‐CD3 Ab as well as the relationship between its expression and regulatory function at the single‐cell level. Our data show that FOXP3 is expressed in a high percentage of activated T cells after in vitro stimulation of human CD4 + CD25 – cells. FOXP3 expression is strongly associated with hyporesponsiveness of activated T cells, but is not directly correlated with their suppressive capabilities, as we demonstrate that it is also expressed in activated nonsuppressive T cells. However, in this nonsuppressive T cell population, FOXP3 expression is transient, while it is stably expressed in activated T cells that do display suppressive function, and in natural CD4 + CD25 ++ T reg cells. These data indicate that expression of endogenous FOXP3, in humans, is not sufficient to induce regulatory T cell activity or to identify T reg cells. See accompanying commentary http://dx.doi.org/10.1002/eji.200636929
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, stimulation with immobilized CD3 mAb is known to increase FoxP3 expression that is strongly associated with hypo-responsiveness by activated CD4+ T-cells and is not directly correlated with suppressive capability 37 . It is, therefore, likely that this is also the case with TGN1412 in the solid phase assay since both TGN1412 and muromonab-CD3 stimulate a similar cytokine response.”
From Severity of the TGN 1412 trial disaster cytokine storm correlated with IL‐2 release (2013) · cites this paper as [37]
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [386]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Cited by
Items 701–800 of 1,000
Teng, M. W. L., Kershaw, M. H., & Smyth, M. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00007-5 · Cited by 31
F protein increases CD4+CD25+ T cell population in patients with chronic hepatitis C
Hashempour, T., Bamdad, T., Bergamini, A., Lavergne, J. P., Haj-Sheykholeslami, A., Brakier‐Gingras, L., Ajorloo, M., & Merat, S. (2015) · Pathogens and Disease · doi:10.1093/femspd/ftv022 · Cited by 15
Hill, D. L., Eastaff‐Leung, N., Bresatz, S., Warner, N. L., Ruitenberg, J. J., Krumbiegel, D., Pederson, S., McInnes, N. J., Brown, C. Y., Sadlon, T. J., et al. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.18 · Cited by 14
Venkatasubramanian, S., Dhiman, R., Paidipally, P., Cheekatla, S. S., Tripathi, D., Welch, E., Tvinnereim, A., Jones, B., Theodorescu, D., Barnes, P. F., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004617 · Cited by 14
“tb in human monocytes and alveolar macrophages [11], [47], [48].”
BackgroundMethodGunnlaugsdottir, B., Maggadottir, S. M., Skaftadóttir, I., & Ludviksson, B. R. (2012) · Scandinavian Journal of Immunology · doi:10.1111/sji.12009 · Cited by 14
Adoptive cell transfer in autoimmune hepatitis
Czaja, A. J. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1019470 · Cited by 15
“Other activated lymphocytes may express Foxp3 [18], and the low or absent expression of CD127 (IL-7 receptor) [19], the presence of CD39 [20] and the demonstration of sitespecific demethylation of the Foxp3 gene are other features that typify this population [21].”
BackgroundZewdie, M., Howe, R., Hoff, S. T., Doherty, T. M., Getachew, N., Tarekegne, A., Tessema, B., Yamuah, L. K., Aseffa, A., & Abebe, M. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.06.007 · Cited by 16
Meng, Z., Wu, J., Zhou, M. L., Sun, S., Miao, S.-Y., Han, H.-L., Chen, L., & Xiong, X. (2019) · International Journal of COPD · doi:10.2147/copd.s208977 · Cited by 16
“We observed that CD25 and Foxp3 were gradually upregulated in naive CD4+ T cells 7 days following the activation (Figure 3A), which are in agreement with previous studies demonstrating that their expressions are only a consequence of the activation status in virtually all activated T-cells.10,11 Interestingly, CD25 wa…”
ResultTreating arthritis by immunomodulation: is there a role for regulatory T cells?
Wehrens, E. J., van Wijk, F., Roord, S. T. A., Albani, S., & Prakken, B. J. (2010) · Rheumatology · doi:10.1093/rheumatology/keq130 · Cited by 17
Hong, J., Li, H., Chen, M., Zang, Y. C. Q., Skinner, S. M., Killian, J. M., & Zhang, J. (2009) · International Immunology · doi:10.1093/intimm/dxp100 · Cited by 14
“It has been shown that transient expression of FOXP3 can be induced during T-cell activation ( 44 ).”
BackgroundHoming in on Acute Graft vs. Host Disease: Tissue-Specific T Regulatory and Th17 Cells
Engelhardt, B. G., & Crowe, J. E. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_24 · Cited by 15
Honkanen, J. K., Skarsvik, S., Knip, M., & Vaarala, O. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.904 · Cited by 14
“with the suppressor function of T-cells [12,13].”
BackgroundMethodHumanized mouse as a tool to predict immunotoxicity of human biologics
Yong, K. S. M., Her, Z., Tan, S. Y., Tan, W. W. S., Liu, M., Lai, F., Heng, S. M., Fan, Y., Chang, K. T. E., Wang, C.-I., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.553362 · Cited by 13
“ICOS Tregs Have Phenotypic Characteristics of Tregs In published clinical studies, FOXP3 expression has been associated in T cells with a regulatory or suppressive phenotype (46, 47).”
BackgroundHeterogeneity and subtypes of CD4+ regulatory T cells: implications for tumor therapy
Lin, H., Xu, Y., & Lin, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1291796 · Cited by 15
Pevec, B., Pevec, M. R., Marković, A. S., Batišta, I., Rijavec, M., Šilar, M., Košnik, M., & Korošec, P. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000338289 · Cited by 13
Immunomodulation by Filarial Parasites
Rajamanickam, A., & Babu, S. (2013) · NIRT Institutional Scholarship Repository (National Institute of Research in Tuberculosis) · Cited by 16
Human Immune Monitoring Techniques during Food Allergen Immunotherapy
Rust, B. J., & Wambre, E. R. (2017) · Current Allergy and Asthma Reports · doi:10.1007/s11882-017-0689-y · Cited by 13
Human renal tubular epithelial cells suppress alloreactive T cell proliferation
Demmers, M. W. H. J., Korevaar, S. S., Rhijn, M. R.-V., van den Bosch, T. P. P., Hoogduijn, M. J., Betjes, M. G. H., Weimar, W., Baan, C. C., & Rowshani, A. T. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12469 · Cited by 13
Hölttä, V., Sipponen, T. M., Westerholm‐Ormio, M., Salo, H. M., Kolho, K., Färkkilä, M. A., Savilahti, E., Vaarala, O., & Klemetti, P. (2012) · ISRN Gastroenterology · doi:10.5402/2012/505432 · Cited by 13
Treg Vaccination in Autoimmune Type 1 Diabetes
Serr, I., Weigmann, B., Franke, R. K., & Daniel, C. (2013) · BioDrugs · doi:10.1007/s40259-013-0060-3 · Cited by 15
Zandian, M., Mott, K. R., Allen, S. J., Chen, S., Arditi, M., & Ghiasi, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016820 · Cited by 13
“FoxP3 expression in Teff cells and its maintenance in Treg cells are both dependent on IL-2 [33,34].”
BackgroundTreg-specific deletion of the phosphatase SHP-1 impairs control of inflammation in vivo
Gu, Q., Tung, K. S. K., & Lorenz, U. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139326 · Cited by 11
Hu, D., Liu, X., Zeng, W., Weiner, H. L., & Ritz, J. (2011) · European Journal of Immunology · doi:10.1002/eji.201141618 · Cited by 12
Regulatory T Cells and the Risk of CMV End-Organ Disease in Patients With AIDS
Weinberg, A., Bosch, R. J., Bennett, K. K., Tovar-Salazar, A., Benson, C. A., Collier, A. C., Zolopa, A. R., Gulick, R. M., Wohl, D. A., Polsky, B., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000095 · Cited by 12
Ghazalsofala, R., Rezaee, S. A., Rafatpanah, H., Vakili, R., Ghazvini, K., Heidarnejad, F., Sobhani, S., Valizadeh, N., Azami, M., Rahimzadegan, M., et al. (2015) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.8(4)2015.17726 · Cited by 12
MiR302c, Sp1, and NFATc2 regulate interleukin‐21 expression in human CD4+CD45RO+ T lymphocytes
El‐Said, H., Fayyad‐Kazan, M., Aoun, R., Borghol, N., Skafi, N., Rouas, R., Vanhamme, L., Mourtada, M., Ezzeddine, M., Burny, A., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27151 · Cited by 13
“…several studies (Gavin et al., 2006; Jandus, Bioley, Speiser, & Romero, 2008; Morgan et al., 2005; Wang, Ioan‐Facsinay, Van der voort, Huizinga, & Toes, 2007; Wang, Zheng, Giscombe, & Lefvert, 2001) showed that activation of human T cells can transiently induce the expression of genes, it was…”
Forkhead Box P Family Members at the Crossroad Between Tolerance and Immunity: A Balancing Act
Fleskens, V., & van Boxtel, R. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.816698 · Cited by 13
Son, J.-S., Sahoo, A., Chae, C.-S., Hwang, J.-S., Park, Z., & Im, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.126 · Cited by 12
Perspectives on Regulatory T Cell Therapies
Probst‐Kepper, M., ger, A. K. O., Garritsen, H., & Buer, J. (2009) · Transfusion Medicine and Hemotherapy · doi:10.1159/000235929 · Cited by 12
Guo, L., Tian, J., Marinova, E., Zheng, B. Q., & Han, S. (2009) · European Journal of Immunology · doi:10.1002/eji.200939404 · Cited by 12
Zahorchak, A. F., Raimondi, G., & Thomson, A. W. (2009) · Transplantation · doi:10.1097/tp.0b013e3181ba6b1f · Cited by 12
“Unlike the mouse, where Foxp3 is a Tregrestricted (albeit intranuclear) marker (14), Foxp3 (and CTLA4) is transiently expressed by activated human T cells that lack regulatory function (15, 16).”
BackgroundPerros, F., Cohen‐Kaminsky, S., & Humbert, M. J. C. (2008) · Respiration · doi:10.1159/000114655 · Cited by 12
Delacher, M., Barra, M. M., Herzig, Y., Eichelbaum, K., Rafiee, M.-R., Richards, D. M., Träger, U., Hofer, A.-C., Kazakov, A., Braband, K. L., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101127 · Cited by 11
“Unlike in mice, in the human system, a certain percentage of T cells express FOXP3 upon activation in vitro (Gavin et al., 2006; Walker et al., 2003; Wang et al., 2007).”
BackgroundHTLV-1 induces an inflammatory CD4+CD8+ T cell population in HTLV-1–associated myelopathy
Maher, A. K., Aristodemou, A., Giang, N., Tanaka, Y., Bangham, C. R. M., Taylor, G. P., & Dominguez‐Villar, M. (2024) · JCI Insight · doi:10.1172/jci.insight.173738 · Cited by 15
“While HTLV-1 infection has been shown to increase Foxp3 + expression, higher Foxp3 expression in DP T cells relative to CD8 + SP T cells could be indicative of an activated non-regulatory phenotype (44–46).”
Elusive modes of Foxp3 activity in versatile regulatory T cells
He, M.-H., & Feng, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1533823 · Cited by 13
Cheung, Y.-H., Landolt-Marticorena, C., Lajoie, G., & Wither, J. (2011) · Genes and Immunity · doi:10.1038/gene.2010.71 · Cited by 11
Foxp3 positive regulatory T cells: a functional regulation by the E3 ubiquitin ligase Itch
Su, J., & Liu, Y. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0192-1 · Cited by 12
“In addition, in most cases, TGF-β-induced Foxp3+ T cells did not exhibit suppressive function [56–59].”
BackgroundAlonso‐Guallart, P., Zitsman, J. S., Stern, J. M., Kofman, S. B., Woodland, D. C., Ho, S.-H., Sondermeijer, H. P., Bühler, L. H., Griesemer, A., Sykes, M., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15313 · Cited by 11
Emerging Role of EGFR Mutations in Creating an Immune Suppressive Tumour Microenvironment
Kapoor, S. S., & Zaiss, D. M. W. (2021) · Biomedicines · doi:10.3390/biomedicines10010052 · Cited by 12
“In humans, other immune cells, including activated CD4 T-cells, express FoxP3 [52] and some reports even suggest that FoxP3 could be expressed by tumour cells as well [53].”
BackgroundInfluentialDiddens, J., Lepennetier, G., Friedrich, V., Schmidt, M., Brand, R. M., Georgieva, T., Hemmer, B., & Lehmann‐Horn, K. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200185 · Cited by 12
Blinova, V. G., Gladilina, Y. A., Abramova, A. A., Eliseeva, D. D., Vtorushina, V. V., Shishparenok, A. N., & Zhdanov, D. D. (2023) · Cells · doi:10.3390/cells13010077 · Cited by 14
“Although the expression of FoxP3 is considered the definitive marker of Tregs, several studies have suggested that it can also be expressed in human activated nonregulatory CD4 + T cells [84–86].”
BackgroundEkong, U. D., Mathew, J. M., Melín‐Aldana, H., Wang, D., & Alonso, E. M. (2012) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2012.01648.x · Cited by 11
Morse, M. A., Hobeika, A. C., Serra, D. M., Aird, K. M., McKinney, M. S., Aldrich, A. J., Clay, T. D., Mourich, D. V., Lyerly, H. K., Iversen, P. L., et al. (2011) · Cancer Gene Therapy · doi:10.1038/cgt.2011.63 · Cited by 11
Gómez, J. M. F., Prado, C., López, P., Suárez, A., & Gutiérrez, C. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.05.012 · Cited by 11
Finney, O. C., Lawrence, E., Gray, A. P., Njie, M., Riley, E. M., & Walther, M. R. (2012) · European Journal of Immunology · doi:10.1002/eji.201142164 · Cited by 11
Beşliu, A. N., Bănică, L. M., Lonescu, R., Predețeanu, D., Stăvaru, C., Marica, C. M., Chiţonu, C., Pistol, G. C., Stefănescu, M., & Matache, C. (2009) · PubMed · Cited by 15
Paul, M., Dayal, D., Bhansali, A. K., Dhaliwal, L., & Sachdeva, N. K. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.09.004 · Cited by 12
Kumar, P., Lele, S. S., Ragothaman, V. K., Raghunathan, D., Epstein, A. L., Chiba, S., & Prabhakar, B. S. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900530 · Cited by 11
“the expression of proinflammatory genes, which can exacerbate autoimmune response (29, 34).”
BackgroundBillerbeck, E., Nakamoto, N., Seigel, B., Blum, H. E., Chang, K., & Thimme, R. (2009) · Journal of General Virology · doi:10.1099/vir.0.009837-0 · Cited by 13
“However, the T cells in these studies were stimulated in an antigen-non-specific manner with anti-CD3 and antiCD28, which led to only a transient upregulation of FoxP3 (Gavin et al., 2006; Wang et al., 2007).”
BackgroundUmhoefer, J. M., Arce, M. M., Kasinathan, S., Whalen, S., Dajani, R., Subramanya, S., Goudy, L., Belk, J. A., Zhou, R. W., Pham, M. T. N., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.10.020 · Cited by 17
Dedeoğlu, B., Litjens, N. H. R., de Weerd, A. E., Dor, F. J. M. F., Klepper, M., Reijerkerk, D., Baan, C. C., & Betjes, M. G. H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01416 · Cited by 12
“Furthermore, the usage of FoxP3 expression to identify Tregs can also lead to the identification of activated CD4+ T cells (48).”
BackgroundВасильевич, Б. Е., Tikhonova, M. A., Pronkina, N. V., Kryuchkova, I. V., Васильевна, С. В., Анатольевна, С. С., Ushakova, G. Y., Aristova, T. A., Batorova, D. S., Menyaeva, E. V., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25553 · Cited by 10
“The studying subset may include some quantity of activated convenient T cells that actually not suppressive, but hyporesponsive [21].”
BackgroundLozano, T., Casares, N., Martín-Otal, C., Anega, B., Gorraiz, M., Parker, J., Ruiz, M., Belsúe, V., Pineda‐Lucena, A., Oyarzábal, J., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9020197 · Cited by 10
“This effect could be ascribed to the transient expression of FOXP3 after T cell receptor (TCR) stimulation that might have a regulatory role limiting T-cell proliferation, as it has been suggested previously [11,12,40,41].”
BackgroundValentin-Torres, A., Day, C., Taggart, J. M., Williams, N. S. G., Stubblefield, S. R., Roobrouck, V. D., Beyens, J., & Ting, A. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-93025-x · Cited by 11
Impact of endocrine disruptors on peripheral blood mononuclear cells in vitro: role of gender
Maddalon, A., Cari, L., Iulini, M., Alhosseini, M. N., Galbiati, V., Marinovich, M., Nocentini, G., & Corsini, E. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03592-3 · Cited by 10
“9, panel B), suggesting that here, as in other experimental models, FoxP3 is expressed more by activated T cells than regulatory T cells (Wang et al. 2007).”
Porto, G., Giordano, R. J., Marti, L. C., Stolf, B. S., Pasqualini, R., Arap, W., Kalil, J. E., & Coelho, V. P. C. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021702 · Cited by 10
“Moreover, non-regulatory T cells can express several of these proteins, and activated human T cells transiently express Foxp3 [14].”
BackgroundSatoda, N., Shoji, T., Wu, Y., Fujinaga, T., Chen, F., Aoyama, A., Zhang, J. T., Takahashi, A., Okamoto, T., Matsumoto, I., et al. (2008) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.08.006 · Cited by 10
Bendfeldt, H., Benary, M., Scheel, T., Steinbrink, K., Radbruch, A., Herzel, H., & Baumgrass, R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00264 · Cited by 12
“The specific CD4 T cells with low FOXP3 expression could be recently activated Th cells (Gavin et al., 2006; Allan et al., 2007; Tran et al., 2007; Wang et al., 2007).”
BackgroundThe companions: regulatory T cells and gene therapy
Eghtesad, S., Morel, P. A., & Clemens, P. R. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03069.x · Cited by 10
Glass, D. R., Mayer-Blackwell, K., Ramchurren, N., Parks, K. R., Durán, G. E., Wright, A. K., Torres, A. N. B., Islas, L., Kim, Y. H., Fling, S. P., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101527 · Cited by 13
Zhdanov, D. D., Gladilina, Y. A., Blinova, V. G., Abramova, A. A., Shishparenok, A. N., & Eliseeva, D. D. (2024) · Biomedicines · doi:10.3390/biomedicines12051022 · Cited by 11
“Although the FoxP3 transcription factor is studied as the specific definitive marker of Tregs, several works have suggested that it can also be expressed in human activated non-regulatory CD4 + T cells [91–93].”
BackgroundJefferson, L., Lima, P., & Archer, S. L. (2025) · Clinical Science · doi:10.1042/cs20257363 · Cited by 10
“These changes include a decrease in the number of anti-inflammatory regulatory T cells [58,59], an increase in inflammatory T helper cells [60,61], a decrease in natural killer cells [62] and an increase in macrophages [40,42].”
FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2
Fleskens, V., Mokrý, M., van der Leun, A. M., Huppelschoten, S., Pals, C. E. G. M., Peeters, J. G. C., Coenen, S., Cardoso, B. A., Barata, J. T., van Loosdregt, J., et al. (2015) · Oncogene · doi:10.1038/onc.2015.481 · Cited by 10
Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
Martin, D., Rödel, F., Hehlgans, S., Looso, M., Ziegler, P. K., Fleischmann, M., Diefenhardt, M., Fries, L., Kalinauskaitė, G., Tinhofer, I., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00585-y · Cited by 10
Williams, K. M., Dotson, A. L., Otto, A. R., Kohlmeier, J. E., & Benedict, S. H. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.08.010 · Cited by 9
Melenhorst, J. J., Scheinberg, P., Lu, J., Ambrozak, D. R., Sosa, E., Zhao, L., Hensel, N. F., Savani, B. N., Douek, D. C., Price, D. A., et al. (2008) · Cytotherapy · doi:10.1080/14653240701853536 · Cited by 9
Barth, S. D., Kaaks, R., Johnson, T., Katzke, V. A., Gellhaus, K., Schulze, J., Olek, S., & Kuhn, T. E. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.07.035 · Cited by 12
“Since activated human conventional CD4+ T cells can also express CD25 and FOXP3 (Wang et al., 2007) whereas TSDR demethylation is not shared by activated T cells (Baron et al.”
BackgroundInfluentialImmunohistochemical characterization of feline lymphoplasmacytic anterior uveitis
Crossfield, L., Fortuna, L., Carling, R., Scurrell, E. J., Riera, M. M., Chang, Y., Dawson, C., Pittaway, R., Yeung, I. Y. L., Thaung, C., et al. (2018) · Veterinary Ophthalmology · doi:10.1111/vop.12569 · Cited by 9
“FoxP3 can be transiently expressed by conventional, nonregulatory T-cells; therefore, positive labeling does not necessarily correspond to Tregs specifically.(10) However, despite this caveat, previous reports have demonstrated cross-reactivity with this particular anti-human FoxP3 clone with feline tissue.”
BackgroundThe frequency of Treg subsets distinguishes disease activity in ANCA vasculitis
Agosto‐Burgos, C., Wu, E. Y., Iannone, M. A., Hu, Y., Hogan, S. L., Henderson, C. D., Kennedy, K. B., Blazek, L. N., Herrera, C. A., Munson, D., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1428 · Cited by 9
Stigliani, S., Croce, M., Morandi, F., Scaruffi, P., Rigo, V., Carlini, B., Manzitti, C., Gigliotti, A. R., Tonini, G. P., Pistoia, V., et al. (2015) · BioMed Research International · doi:10.1155/2015/347867 · Cited by 10
Effect of biologic agents on regulatory T cells
Serres, S. A. D., Yeung, M. Y., Mfarrej, B. G., & Najafian, N. (2011) · Transplantation Reviews · doi:10.1016/j.trre.2010.11.002 · Cited by 9
“However, the usefulness of detecting FoxP3 as a Treg marker in human studies is limited by its intracellular localization and transient expression on recently activated CD4 T cells [13].”
BackgroundAskenasy, N. (2016) · Immunology · doi:10.1111/imm.12581 · Cited by 9
Bassler, K. E., Schmidleithner, L., Shakiba, M. H., Elmzzahi, T., Köhne, M., Floess, S., Scholz, R., Ohkura, N., Sadlon, T. J., Klee, K., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1107397 · Cited by 9
“This is in agreement with previous reports describing CD4 T cells in humans which upregulate the expression of FOXP3 without the acquisition of a suppressive capacity (70, 71).”
ResultThe evolution of biomarkers in rheumatoid arthritis: From clinical research to clinical care
van den Broek, T., Tesser, J., & Albani, S. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.11.1773 · Cited by 8
“However, it has been shown that human effector T cells can transiently upregulate Foxp3 without any regulatory functions and thus increase the Foxp3 cell frequency [116] .”
BackgroundAngin, M., Klarenbeek, P. L., King, M., Sharma, S. M., Moodley, E. S., Rezai, A., Trocha, A. K., Tóth, I., Chan, A. T., Goulder, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086920 · Cited by 9
“In humans FOXP3 does not represent an exclusive Treg marker and can transiently be expressed by activated conventional T cells [33] to negatively regulate their proliferation and cytokine production, therefore limiting their activation state [34].”
BackgroundAdoptive Treg Cell-Based Immunotherapy: Frontier Therapeutic Aspects in Rheumatoid Arthritis
Zavvar, M., Assadiasl, S., Zargaran, S., Akhtari, M., Poopak, B., Dinarvand, R., Fatahi, Y., Tayebi, L., Soleimanifar, N., & Nicknam, M. H. (2020) · Immunotherapy · doi:10.2217/imt-2020-0071 · Cited by 8
“On the other hand, Foxp3 express in activated conventional Tcells (TCons) transiently results in unspecific staining of human TEff cells (10,11) and is highly along with hypo-responsiveness to these cells (12).”
BackgroundTranscriptional Control of Regulatory T Cells in Cancer: Toward Therapeutic Targeting?
Stéphan, P., Lautraite, R., Voisin, A., & Grinberg‐Bleyer, Y. (2020) · Cancers · doi:10.3390/cancers12113194 · Cited by 10
“For instance, FOXP3 can also be expressed by a subset of effector T cells [35,36].”
BackgroundLehtoviita, A., Rossi, L. H., Kekäläinen, E., Sairanen, H. I., & Arstila, T. P. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02307.x · Cited by 8
T cells stimulatedin vitrohave a suppressive function but do not contain only regulatory T cells
Valencic, E., Piscianz, E., Tommasini, A., & Granzotto, M. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03502.x · Cited by 9
Link, M., Salur, L., Kisand, K. E., Tillmann, V., & Uibo, R. (2008) · Apmis · doi:10.1111/j.1600-0463.2008.00889.x · Cited by 8
Mowat, A. M., & Garside, P. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0101 · Cited by 8
Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes
Lee, K. P., Epstein, B. E., Lake, C. M., & Snow, A. L. (2023) · Frontiers in Cell Death · doi:10.3389/fceld.2023.1281137 · Cited by 7
“Although this short-lived FOXP3 expression is not sufficient to endow Tcons with suppressive function, conflicting reports suggest it may regulate Tcon proliferation and cytokine production (Allan et al., 2007; Wang et al., 2007; Cavatorta et al., 2012; McMurchy et al., 2013).”
Manurung, M. D., Sonnet, F., Hoogerwerf, M.-A., Janse, J. J., Kruize, Y. C. M., de Bes-Roeleveld, L. M., König, M. H., Loukas, A. C., Dewals, B. G., Supali, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50313-0 · Cited by 9
“This segregation was largely driven by increased frequencies ofplasmacytoid dendriticcells (pDC, cluster 43), CD45RA + Foxp3 + CD4 + T cells (resting T regs , cluster 7), and basophils (cluster 35) as well as decreased frequencies of memory CD4 + T cells (clusters 4, 9, and 19) after infection (Fig.”
InfluentialTranscriptional fingerprinting of regulatory T cells: ensuring quality in cell therapy applications
Cheng, Z., Wang, L., Honaker, Y., Cincotta, S. A., Page, C. E., Vollhardt, S., Yuan, V., Long, S. A., Xiao, Y., Beilke, J. N., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1602172 · Cited by 8
“D14 Teff, however, had moderate expression of FOXP3, which has been well described as being transiently upregulated in activated Teff cells (35, 36).”
Chen, R., Li, C., Zheng, J., Fan, Z., Li, L., Chen, M., Chen, B., & Zhang, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1403420 · Cited by 10
“Moreover, overactivation of Th1 and Th17 cells and functional de fi ciency of Tregs have been implicated in IBD (10 – 12).”
BackgroundThe MicroRNA Regulatory Network in Normal- and HTLV-1-Transformed T Cells
D’Agostino, D. M., Zanovello, P., Watanabe, T., & Ciminale, V. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-394280-7.00002-6 · Cited by 9
“As described in Section III, miR-21 is a positive regulator of Foxp3 expression; therefore upregulation of miR-21 could explain the high levels of Foxp3 transiently detected in TCR-stimulated CD4þ T cells (Rouas et al., 2009; Wang et al., 2007).”
BackgroundFortuna, L., Relf, J., Chang, Y., Hibbert, A., Martineau, H. M., & Garden, O. A. (2016) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2016.06.006 · Cited by 7
Husseiny, M. I., Fahmy, A. A., Du, W., Gu, A., Garcia, P., Ferreri, K., & KANDEEL, F. R. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00300 · Cited by 7
“T cells transiently upregulate FOXP3 following antigen stimulation but its function in this situation remain unclear (Wang et al., 2007).”
BackgroundImmune Characters and Plasticity of the Sentinel Lymph Node in Colorectal Cancer Patients
Li, X., Tang, J., Du, H., Wang, X., Wu, L., Hu, P., Zhang, H., Zhang, R., & Yang, Y. (2021) · Journal of Immunology Research · doi:10.1155/2021/5516399 · Cited by 16
“Given that Foxp3 is increased after ex vivo stimulation, but not very inhibitory [30, 31], we did not equate increased Foxp3 with the increased inhibition of Tregs.”
BackgroundCosta, V. R., Soileau, A. M., Liu, C., Moeller, C. E., Carossino, M., Langohr, I. M., & Withers, S. S. (2022) · Research in Veterinary Science · doi:10.1016/j.rvsc.2022.04.005 · Cited by 7
PHLPP Signaling in Immune Cells
Lordén, G., Lam, A. J., Levings, M. K., & Newton, A. C. (2022) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-06566-8_5 · Cited by 11
Xu, M., Tan, C., Zhou, J., Huang, X., Dai, Z., Zhu, H., Zhao, Y., Gu, F., Zhou, S., & Fan, J. (2009) · Transplant Immunology · doi:10.1016/j.trim.2009.11.003 · Cited by 7
Plasticity and Overlap of In Vitro–Induced Regulatory T-Cell Markers in Healthy Humans
Wang, H., Daniel, V., Sadeghi, M., & Opelz, G. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.10.060 · Cited by 7
Adaptive immunity in rheumatic diseases – Bystander or pathogenic player?
Scherer, H. U., & Burmester, G. R. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.11.005 · Cited by 13
Velthuis, J. H. L., Hesselink, D. A., Hendrikx, T. K., van der Mast, B. J., Klepper, M., de Greef, G. E., Baan, C. C., & Weimar, W. (2007) · Transplant Immunology · doi:10.1016/j.trim.2007.05.009 · Cited by 7
Sandvik, L. F., Skarstein, K., Krynitz, B., Volchenkov, R., Sviland, L., Leivestad, T., Jonsson, R., & Appel, S. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13151 · Cited by 7
Weissler, K. A., Garcia, V., Kropf, E., Aitken, M., Bedoya, F., Wolf, A. I., Erikson, J., & Caton, A. J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402960 · Cited by 9
“of Foxp3 contrasts with some findings in human and mouse systems in which Foxp3 was found to be transiently expressed by CD4 T cells at early stages following activation and was not indicative of Treg development (52, 53).”
ResultDisentangling Tfr cells from Treg cells and Tfh cells: How to untie the Gordian knot
Amiezer, M., & Phan, T. G. (2016) · European Journal of Immunology · doi:10.1002/eji.201646389 · Cited by 10
Mohiuddin, I. H., Pillai, V., Baughman, E. J., Greenberg, B. M., Frohman, E. M., Crawford, M. P., Sinha, S., & Karandikar, N. J. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.05.001 · Cited by 9
“skepticism regarding their functional ability and biological relevance [13, 14].”
In vitro immunoregulatory effects of thymoglobulin on human immune cell subpopulations
Buszko, M., Jakic, B., Ploner, C., Hörtnagl, P., Mayerl, C., Wick, G., & Cappellano, G. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.04.002 · Cited by 7
Metadata
- Authors
- Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Toes, René E. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2006-12-21
- Volume
- 37
- Issue
- 1
- Pages
- 129-138
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1984909066
- Cited by
- 1,011
- References
- 43
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 24 · 2023: 29 · 2022: 25 · 2021: 36 · 2020: 39 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 43 · 2015: 47 · 2014: 61 · 2013: 63 · 2012: 69
- FWCI
- 31.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, regulatory T cells, CD4+ T cell activation, T cell hyporesponsiveness, CD25, anti-CD3 stimulation, human T cells
- MeSH terms
- Cells, Cultured, Humans, Lymphocyte Activation, Time Factors, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Resting Phase, Cell Cycle, Cytokines, Self Tolerance, Coculture Techniques, Cell Proliferation, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.